COMBINATION DRUG THERAPIES WITH THE NOVEL RNA POLYMERASE I INHIBITOR CX-5461 IMPROVE EFFICACY IN THE TREATMENT OF MULTIPLE MYELOMA

被引：0
|
作者：
Maclachlan, K. [1 ,2 ]
Cuddihy, A. [1 ]
Hein, N. [3 ]
Harrison, S. [2 ]
Hannan, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构：
[1] Peter MacCallum Canc Ctr, Res Div, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] Australian Natl Univ, Dept Canc Biol & Therapeut, Canberra, ACT, Australia
[4] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia
[6] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia
[7] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1240
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [1] Novel Combination Therapies with the RNA Polymerase I Inhibitor CX-5461 Significantly Improve Efficacy in Multiple Myeloma
    Maclachlan, Kylee H.
    Cuddihy, Andrew
    Hein, Nadine
    Cullinane, Carleen
    Harrison, Simon J.
    Hannan, Ross
    Poortinga, Gretchen
    BLOOD, 2017, 130
  • [2] RNA Polymerase I Inhibition with CX-5461 As a Novel Strategy to Target MYC in Multiple Myeloma
    Lee, Hans
    Wang, Hua
    Lin, Heather
    Baladandayuthapani, Veera
    He, Jin
    Jones, Richard Julian
    Kuiatse, Isere
    Gu, Dongmin
    Wang, Zhiqiang
    O'Brien, Sean
    Keats, Jonathan J.
    Yang, Jing
    Davis, Richard Eric
    Orlowski, Robert Z.
    BLOOD, 2015, 126 (23)
  • [3] RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma
    Lee, Hans C.
    Wang, Hua
    Baladandayuthapani, Veerabhadran
    Lin, Heather
    He, Jin
    Jones, Richard J.
    Kuiatse, Isere
    Gu, Dongmin
    Wang, Zhiqiang
    Ma, Wencai
    Lim, John
    O'Brien, Sean
    Keats, Jonathan
    Yang, Jing
    Davis, Richard E.
    Orlowski, Robert Z.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (01) : 80 - 94
  • [4] Novel RNA polymerase I inhibitor CX-5461 suppresses imiquimod-induced experimental psoriasis
    Wu, Xiao
    Yin, Qihui
    Wang, Jie
    Dai, Chaochao
    Wang, Jianli
    Guo, Xiaosun
    Jiang, Fan
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (01) : 91 - 99
  • [5] The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma
    Chang-Won Kang
    Katherine M. Hannan
    Anneke C. Blackburn
    Amos H. P. Loh
    Kuick Chik Hong
    Goh Jian Yuan
    Nadine Hein
    Denis Drygin
    Ross D. Hannan
    Lucy A. Coupland
    Investigational New Drugs, 2022, 40 : 529 - 536
  • [6] Therapeutic efficacy of the novel selective RNA polymerase I inhibitor CX-5461 on pulmonary arterial hypertension and associated vascular remodelling
    Xu, Xia
    Feng, Hua
    Dai, Chaochao
    Lu, Weida
    Zhang, Jun
    Guo, Xiaosun
    Yin, Qihui
    Wang, Jianli
    Cui, Xiaopei
    Jiang, Fan
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (07) : 1605 - 1619
  • [7] The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma
    Kang, Chang-Won
    Hannan, Katherine M.
    Blackburn, Anneke C.
    Loh, Amos H. P.
    Hong, Kuick Chik
    Yuan, Goh Jian
    Hein, Nadine
    Drygin, Denis
    Hannan, Ross D.
    Coupland, Lucy A.
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (03) : 529 - 536
  • [8] Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics
    Haddach, Mustapha
    Schwaebe, Michael K.
    Michaux, Jerome
    Nagasawa, Johnny
    O'Brien, Sean E.
    Whitten, Jeffrey P.
    Pierre, Fabrice
    Kerdoncuff, Pauline
    Darjania, Levan
    Stansfield, Ryan
    Drygin, Denis
    Anderes, Kenna
    Proffitt, Chris
    Bliesath, Josh
    Siddiqui-Jain, Adam
    Omori, May
    Huser, Nanni
    Rice, William G.
    Ryckman, David M.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (07): : 602 - 606
  • [9] rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
    Son, Jinbae
    Hannan, Katherine M.
    Poortinga, Gretchen
    Hein, Nadine
    Cameron, Donald P.
    Ganley, Austen R. D.
    Sheppard, Karen E.
    Pearson, Richard B.
    Hannan, Ross D.
    Sanij, Elaine
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [10] Impact of RNA polymerase I inhibitor CX-5461 on viral kinase-dependent and -independent cytomegalovirus replication
    Westdorp, Kristen N.
    Terhune, Scott S.
    ANTIVIRAL RESEARCH, 2018, 153 : 33 - 38
12345